Jinyu Bio-technology マネジメント

マネジメント基準チェック /24

Jinyu Bio-technologyの CEO はJing Zhangで、 May2019年に任命され、の在任期間は 5.5年です。は、会社の株式の0.55%を直接所有しており、その価値はCN¥ 40.91M 。経営陣と取締役会の平均在任期間はそれぞれ5.3年と2.5年です。

主要情報

Jing Zhang

最高経営責任者

CN¥1.4m

報酬総額

CEO給与比率	n/a
CEO在任期間	5.5yrs
CEOの所有権	0.5%
経営陣の平均在職期間	5.3yrs
取締役会の平均在任期間	2.5yrs

経営陣の近況

Recent updates

The Consensus EPS Estimates For Jinyu Bio-technology Co., Ltd. (SHSE:600201) Just Fell Dramatically

Sep 04

Revenue Miss: Jinyu Bio-technology Co., Ltd. Fell 9.1% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Sep 02

Why We're Not Concerned Yet About Jinyu Bio-technology Co., Ltd.'s (SHSE:600201) 25% Share Price Plunge

Jun 16

Jinyu Bio-technology Co., Ltd. (SHSE:600201) Analysts Are Reducing Their Forecasts For This Year

Apr 30

There's Reason For Concern Over Jinyu Bio-technology Co., Ltd.'s (SHSE:600201) Price

Mar 21

Does This Valuation Of Jinyu Bio-technology Co., Ltd. (SHSE:600201) Imply Investors Are Overpaying?

Feb 28

CEO（最高経営責任者

Jing Zhang (41 yo)

5.5yrs

在職期間

CN¥1,392,300

報酬

Ms. Jing Zhang serves as President of Jinyu Bio-technology Co., Ltd. since May 2019 and is its Vice Chairman. She serves as Director of Jinyu Bio-technology Co., Ltd.since May 2016 and served as its Vice...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Jing Zhang	Vice Chairman & President	5.5yrs	CN¥1.39m	0.55% CN¥ 40.9m
Min Peng	CFO, Secretary of the Board of Directors & Director	2.5yrs	CN¥1.62m	データなし
Rong Li	Vice President	5.3yrs	CN¥660.00k	0.075% CN¥ 5.6m

5.3yrs

平均在職期間

41yo

平均年齢

経験豊富な経営陣: 600201の経営陣は経験豊富で経験豊富です（平均在職期間は5.3年）。

取締役

名称	ポジション	在職期間	報酬	所有権
Jing Zhang	Vice Chairman & President	8.5yrs	CN¥1.39m	0.55% CN¥ 40.9m
Min Peng	CFO, Secretary of the Board of Directors & Director	2.5yrs	CN¥1.62m	データなし
Chong Yu Zhang	Chairman	no data	CN¥1.59m	2.06% CN¥ 153.4m
Ning Li	Supervisor	2.5yrs	CN¥238.80k	0.012% CN¥ 894.1k
Chang'e Shen	Independent Director	2.5yrs	CN¥136.80k	データなし
Jiulian Chen	Supervisor	2.5yrs	データなし	0.0032% CN¥ 239.9k
Riming Gao	Director	2.5yrs	CN¥1.39m	0.018% CN¥ 1.4m
Zhen Wu	Independent Director	2.5yrs	CN¥75.50k	データなし
Ming Geng	Independent Director	1.8yrs	データなし	データなし

2.5yrs

平均在職期間

48yo

平均年齢

経験豊富なボード: 600201の取締役会は経験豊富ではない ( 2.5年の平均在任期間) ため、新しい取締役会が必要であると考えられます。

Jinyu Bio-technology マネジメント

マネジメント 基準チェック /24

主要情報

経営陣の近況

Jinyu Bio-technology Co., Ltd., Annual General Meeting, May 27, 2024

Less than half of directors are independent

Recent updates

Jinyu Bio-technology Co., Ltd. (SHSE:600201) announces an Equity Buyback for 15,984,015 shares, representing 1.43% for CNY 160 million.

Jinyu Bio-technology Co., Ltd. (SHSE:600201) announces an Equity Buyback for 15,984,015 shares, representing 1.43% for CNY 160 million.

New minor risk - Profit margin trend

Third quarter 2024 earnings released: EPS: CN¥0.04 (vs CN¥0.14 in 3Q 2023)

Jinyu Bio-technology Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024

Investor sentiment improves as stock rises 17%

Consensus revenue estimates fall by 17%

The Consensus EPS Estimates For Jinyu Bio-technology Co., Ltd. (SHSE:600201) Just Fell Dramatically

Revenue Miss: Jinyu Bio-technology Co., Ltd. Fell 9.1% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Price target decreased by 12% to CN¥8.34

Second quarter 2024 earnings: EPS in line with expectations, revenues disappoint

Jinyu Bio-technology Co., Ltd. to Report First Half, 2024 Results on Aug 31, 2024

Why We're Not Concerned Yet About Jinyu Bio-technology Co., Ltd.'s (SHSE:600201) 25% Share Price Plunge

Investor sentiment deteriorates as stock falls 20%

Now 20% overvalued after recent price rise

New minor risk - Shareholder dilution

Jinyu Bio-technology Co., Ltd., Annual General Meeting, May 27, 2024

Consensus revenue estimates fall by 13%

Jinyu Bio-technology Co., Ltd. (SHSE:600201) Analysts Are Reducing Their Forecasts For This Year

Price target decreased by 8.9% to CN¥9.38

Jinyu Bio-technology Co., Ltd. to Report Q1, 2024 Results on Apr 30, 2024

Price target decreased by 8.0% to CN¥9.48

There's Reason For Concern Over Jinyu Bio-technology Co., Ltd.'s (SHSE:600201) Price

Does This Valuation Of Jinyu Bio-technology Co., Ltd. (SHSE:600201) Imply Investors Are Overpaying?

Now 20% overvalued

Now 26% overvalued

Investor sentiment deteriorates as stock falls 17%

Jinyu Bio-technology Co., Ltd. to Report Fiscal Year 2023 Results on Apr 26, 2024

Third quarter 2023 earnings: EPS exceeds analyst expectations

Price target decreased by 10% to CN¥10.33

Second quarter 2023 earnings released: EPS: CN¥0.024 (vs CN¥0.02 in 2Q 2022)

First quarter 2023 earnings released: EPS: CN¥0.10 (vs CN¥0.07 in 1Q 2022)

Price target increased by 8.4% to CN¥11.82

Jinyu Bio-technology Co., Ltd. announced that it expects to receive CNY 799.999997 million in funding from Inner Mongolia Jinyu Biological Holdings Co., Ltd., and other investors

Price target increased to CN¥11.87

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.11 (vs CN¥0.14 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.02 (vs CN¥0.041 in 2Q 2021)

Consensus revenue estimates fall by 20%

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Jinyu Bio-technology Co., Ltd. (SHSE:600201) announces an Equity Buyback for CNY 300 million worth of its shares.

Price target decreased to CN¥22.80

Third quarter 2021 earnings released: EPS CN¥0.14 (vs CN¥0.10 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.041 (vs CN¥0.028 in 2Q 2020)

First quarter 2021 earnings released: EPS CN¥0.19 (vs CN¥0.13 in 1Q 2020)

New 90-day low: CN¥20.00

New 90-day low: CN¥21.54

New 90-day low: CN¥22.60

Third quarter earnings released

Third-quarter earnings released: Revenue beats expectations, earnings disappoint

New 90-day low: CN¥23.40

Jinyu Bio-technology Co., Ltd. to Report Q3, 2020 Results on Oct 23, 2020

Price target raised to CN¥30.56

Earnings released

Jinyu Bio-technology Co., Ltd. to Report First Half, 2020 Results on Aug 15, 2020

CEO（最高経営責任者

在職期間

報酬

リーダーシップ・チーム

平均在職期間

平均年齢

取締役

平均在職期間

平均年齢

マネジメント基準チェック /24